Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen.

Applied and environmental microbiology - 15 Feb 2018

Bottero D, Zurita M E, Gaillard M E, Bartel E, Vercellini C, Hozbor D

Abstract excerpt

Bordetella bronchiseptica, a Gram-negative bacterium, causes chronic respiratory tract infections in a wide variety of mammalian hosts, including humans (albeit rarely). We recently designed Bordetella pertussis and Bordetella parapertussis experimental vaccines based on outer membrane vesicles (OMVs) derived from each pathogen, and we obtained protection against the respective infections in mice. Here, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Bacterial
Share to Bacterial Vaccines

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Bordetella bronchiseptica

Share to Immunity, Cellular

Share to Immunity, Humoral

Share to Immunization

Share to Respiratory Tract Infections

Share to Th17 Cells

Source

Open in PubMed Open full text

Identifiers

PMID: 29180369
DOI: 10.1128/AEM.01877-17
PMCID: PMC5795063

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen.PMID 29180369Read ↗

Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine.Semantic proximity Read ↗

Outer membrane vesicles derived from Bordetella pertussis are potent adjuvant that drive Th1-biased responseSemantic proximity Read ↗

Mechanisms of bordetella pathogenesisSemantic proximity Read ↗

A novel outer membrane vesicle adjuvant improves vaccine protection against Bordetella pertussisSemantic proximity Read ↗

<em>Bordetella pertussis</em> Infection: From Immune Pathogenesis to Next-Generation VaccinesSemantic proximity Read ↗

Bordetella pertussistransmission: Graphical Abstract Figure.Semantic proximity Read ↗

Bordetella Type III Secretion Injectosome and Effector ProteinsSemantic proximity Read ↗

BvgR is important for virulence-related phenotypes in Bordetella bronchiseptica.Semantic proximity Read ↗

Pertussis: Microbiology, Disease, Treatment, and PreventionSemantic proximity Read ↗

Molecular evolution of the two-component system BvgAS involved in virulence regulation in Bordetella.Semantic proximity Read ↗

Evaluation of the role of the Bvg intermediate phase in Bordetella pertussis during experimental respiratory infection.Semantic proximity Read ↗

Pertussis: a matter of immune modulationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.